Clinical trial
Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4
NCT02772744 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4
- Lead sponsor
- Zagazig University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 1, 2017
- Completion date
- December 31, 2018
- Enrollment
- 250 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.